FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy

Vermont docs received more secret payments

Tools

A March 2007 article in the Journal of the American Medical Association told the story of pharma companies paying physicians in Vermont over $2.7 million between July 2002 and June 2004, but the advocacy group that reported the original findings now says the amount is actually much higher.

According to the organization Public Citizen, the payments total nearly $5 million and "strongly suggest" violations of American Medical Association and PhRMA professional guidelines, which restrict said payments to $100 per doctor, per occassion.

In fact, the group found that more than $3.2 million worth of the payments were greater than $100 each, representing nearly 90 percent of the payments to physicians by drug companies. Twenty-one drugmakers were said to have kept the payments under wraps. The companies involved included Abbott Labs, AstraZeneca, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Merck and Roche. 

- see the full story at Pharmalot 

Related Articles:
Lilly tops VT's doc-marketing list
Psych docs mull ties with drugmakers
Arms twisted, pharma promises disclosure
Docs go cold turkey on industry pay
Arms twisted, pharma promises disclosure
Americans want doc payments disclosed

More stories about Roche   Payments   Merck   GlaxoSmithKline   Bristol-Myers Squibb   Bayer   AstraZeneca   Abbott Labs  

Comments

vermont, my God this is happening all over the US. TonS of proof even in the Federal arena. Reps buying pharmacists just to get them to order drugs for sales credit. all unnecessary.

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.